<DOC>
	<DOCNO>NCT02833675</DOCNO>
	<brief_summary>Diagnosis angioedema ( AE ) difficult especially emergency room . Two form evoke : histaminic AE ( allergic , represent 95 % case ) bradykinic AE ( hereditary acquire deficiency , without C1 Inhibitor ) rarer severe prognosis . The distinction base clinical feature ( spontaneous crisis duration , presence concomitant hive , atopic history ... ) . Sometimes could difficult make difference . Nowadays , biological marker crisis . The search biomarkers could improve diagnostic therapeutic management AE . Previous work identify target : D-dimer , C4 , VE-cadherin . We want know sensitivity specificity marker . We conduct prospective study evaluate D-dimer assay , complement VE-cadherin episode AE . Three group patient test : bradykinic AE ( peripheral abdominal attack ) , histaminic AE , abdominal pain ( non-bradykinic non-histaminic etiology ) time ( day 0 ) distance crisis ( D7 ) .</brief_summary>
	<brief_title>Determination Specific Biomarkers Angioneurotic Crisis</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<criteria>Histaminergic bradykinin angioedema Abdominal pain child &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>angioedema</keyword>
	<keyword>C1Inhibitor</keyword>
	<keyword>bradykinin</keyword>
	<keyword>Histamin</keyword>
</DOC>